These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 11317198)

  • 1. Using medication history to measure confounding by indication in assessing calcium channel blockers and other antihypertensive therapy.
    Leader S; Mallick R; Roht L
    J Hum Hypertens; 2001 Mar; 15(3):153-9. PubMed ID: 11317198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Consumption of antihypertensive agents in obese patients: a cross-sectional study in a sample of 3,291 wage-earners in the Toulous region].
    Lapeyre-Mestre M; Sulem P; Chastan E; Niezborala M; Briant D; Jansou P; Sanguignol F; Montastruc JL
    Arch Mal Coeur Vaiss; 2000 Aug; 93(8):925-9. PubMed ID: 10989731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium antagonists and cardiovascular risk in patients with hypertension and Type 2 diabetes mellitus: evidence from the PIUMA Study. Progetto Ipertensione Umbria Monitoraggio Ambulatoriale.
    Verdecchia P; Schillaci G; Reboldi G; Borgioni C; Ciucci A; Porcellati C
    Diabetes Nutr Metab; 1999 Aug; 12(4):292-9. PubMed ID: 10782756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antihypertensives and myocardial infarction risk: the modifying effect of history of drug use.
    Bourgault C; Elstein E; Baltzan MA; Le Lorier J; Suissa S
    Pharmacoepidemiol Drug Saf; 2001; 10(4):287-94. PubMed ID: 11760488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rationale, design and patient baseline characteristics of OlmeSartan and calcium antagonists randomized (OSCAR) study: a study comparing the incidence of cardiovascular events between high-dose angiotensin II receptor blocker (ARB) monotherapy and combination therapy of ARB with calcium channel blocker in Japanese elderly high-risk hypertensive patients (ClinicalTrials. gov no. NCT00134160).
    Ogawa H; Kim-Mitsuyama S; Jinnouchi T; Matsui K; Arakawa K
    Hypertens Res; 2009 Jul; 32(7):575-80. PubMed ID: 19444280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistence with treatment in newly treated middle-aged patients with essential hypertension.
    Perreault S; Lamarre D; Blais L; Dragomir A; Berbiche D; Lalonde L; Laurier C; St-Maurice F; Collin J
    Ann Pharmacother; 2005 Sep; 39(9):1401-8. PubMed ID: 16076920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 26-week, prospective, open-label, uncontrolled, multicenter study to evaluate the effect of an escalating-dose regimen of trandolapril on change in blood pressure in treatment-naive and concurrently treated adult hypertensive subjects (TRAIL).
    Tytus RH; Burgess ED; Assouline L; Vanjaka A
    Clin Ther; 2007 Feb; 29(2):305-15. PubMed ID: 17472822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
    Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA
    J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of the alpha-adducin G460W polymorphism and angiotensinogen M235T polymorphism on antihypertensive medication and blood pressure.
    Schelleman H; Klungel OH; Witteman JC; Hofman A; van Duijn CM; de Boer A; Stricker BH
    Eur J Hum Genet; 2006 Jul; 14(7):860-6. PubMed ID: 16724011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship between antihypertensive combination therapies comprising diuretics and/or beta-blockers and the risk of new-onset diabetes: a retrospective longitudinal cohort study.
    Liou YS; Ma T; Tien L; Lin CM; Jong GP
    Hypertens Res; 2009 Jun; 32(6):496-9. PubMed ID: 19390541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Initial non-compliance with antihypertensive monotherapy is followed by complete discontinuation of antihypertensive therapy.
    Van Wijk BL; Klungel OH; Heerdink ER; de Boer A
    Pharmacoepidemiol Drug Saf; 2006 Aug; 15(8):587-93. PubMed ID: 16586465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antihypertensive drugs and new-onset diabetes: a retrospective longitudinal cohort study.
    Jong GP; Chang MH; Tien L; Li SY; Liou YS; Lung CH; Ma T
    Cardiovasc Ther; 2009; 27(3):159-63. PubMed ID: 19689614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of beta-blockers for uncomplicated hypertension in the elderly: a cause for concern.
    Tu K; Campbell NR; Chen Z; McAlister FA
    J Hum Hypertens; 2007 Apr; 21(4):271-5. PubMed ID: 17287848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient satisfaction with antihypertensive therapy.
    Chen K; Chiou CF; Plauschinat CA; Frech F; Harper A; Dubois R
    J Hum Hypertens; 2005 Oct; 19(10):793-9. PubMed ID: 15951740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antihypertensive drug prescription trends at the primary health care centres in Bahrain.
    Jassim al Khaja KA; Sequeira RP; Wahab AW; Mathur VS
    Pharmacoepidemiol Drug Saf; 2001 May; 10(3):219-27. PubMed ID: 11501335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The development of new-onset type 2 diabetes associated with choosing a calcium channel blocker compared to a diuretic or beta-blocker.
    Kuti EL; Baker WL; White CM
    Curr Med Res Opin; 2007 Jun; 23(6):1239-44. PubMed ID: 17559720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Rahman M; Pressel S; Davis BR; Nwachuku C; Wright JT; Whelton PK; Barzilay J; Batuman V; Eckfeldt JH; Farber M; Henriquez M; Kopyt N; Louis GT; Saklayen M; Stanford C; Walworth C; Ward H; Wiegmann T
    Arch Intern Med; 2005 Apr; 165(8):936-46. PubMed ID: 15851647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistence and discontinuation patterns of antihypertensive therapy among newly treated patients: a population-based study.
    Bourgault C; Sénécal M; Brisson M; Marentette MA; Grégoire JP
    J Hum Hypertens; 2005 Aug; 19(8):607-13. PubMed ID: 15920457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of a therapeutic interchange from high-dose calcium channel blockers to a fixed-dose combination of amlodipine/benazepril in patients with moderate-to-severe hypertension.
    Hilleman DE; Reyes AP; Wurdeman RL; Faulkner M
    J Hum Hypertens; 2001 Aug; 15(8):559-65. PubMed ID: 11494095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Initial angiotensin-converting enzyme inhibitor/calcium channel blocker combination therapy achieves superior blood pressure control compared with calcium channel blocker monotherapy in patients with stage 2 hypertension.
    Jamerson KA; Nwose O; Jean-Louis L; Schofield L; Purkayastha D; Baron M
    Am J Hypertens; 2004 Jun; 17(6):495-501. PubMed ID: 15177521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.